Pfizer
PFE
PFE
2,240 hedge funds and large institutions have $154B invested in Pfizer in 2017 Q4 according to their latest regulatory filings, with 282 funds opening new positions, 859 increasing their positions, 861 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% less repeat investments, than reductions
Existing positions increased: 859 | Existing positions reduced: 861
7% less funds holding in top 10
Funds holding in top 10: 176 → 163 (-13)
27% less call options, than puts
Call options by funds: $937M | Put options by funds: $1.28B
Holders
2,240
Holding in Top 10
163
Calls
$937M
Puts
$1.28B
Top Buyers
| 1 | +$441M | |
| 2 | +$414M | |
| 3 | +$310M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$289M |
| 5 |
Bank of New York Mellon
New York
|
+$273M |
Top Sellers
| 1 | -$595M | |
| 2 | -$437M | |
| 3 | -$261M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$244M |
| 5 |
Renaissance Technologies
New York
|
-$167M |